Open Payments

MASSACHUSETTS EYE AND EAR INFIRMARY

Type
Teaching hospital
Where
BOSTON, MA
Medicare CCN
220075
Received
$1,528,189 in 43 records, 2022 ($794,301 general, $733,888 research)
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2022General payment16$794,301
2022Research payment27$733,888

By company

CompanyRecordsAmountYears
Bausch & Lomb Americas Inc.5$704,4492022
Alcon Research LLC3$274,0002022
Genentech, Inc.5$272,8442022
Biogen, Inc.6$116,4022022
Celgene Corporation1$100,0002022
Oyster Point Pharma, Inc.5$19,3762022
Medtronic, Inc.1$8,0002022
Inspire Medical Systems, Inc.4$7,3152022
MED-EL Corporation1$6,5302022
Optinose US, Inc.2$5,7012022
ABBVIE INC.1$5,0002022
Stryker Corporation1$3,0002022
Advanced Bionics, LLC2$2,1802022
Spark Therapeutics, Inc.1$1,8372022
Philips North America LLC1$1,2002022
EMD Millipore Corporation1$1852022
Grace Medical, Inc.1$1352022
Gyrus ACMI, Inc.2$322022

By nature of payment

NatureRecordsAmount
Royalty or License12$768,301
Research payment27$733,888
Grant2$15,000
Space rental or facility fees (teaching hospital only)2$11,000

Records

DateCompanyAmountNatureFormProductStudyYear
2022-12-31Philips North America LLC$1,200Research paymentIn-kind items and services(6260) Ingenia 3 0T R5 Device, Medical DeviceWF-010536 / Evaluation of Image Quality of 3D Synthetic MRI in Children2022
2022-12-06Alcon Research LLC$82,000Research paymentCash or cash equivalentA Phase 3 Study Evaluating the Safety and Efficacy of AR-15512, a Cold Thermoreceptor Modulator, for the Treatment of Dr2022
2022-11-23Gyrus ACMI, Inc.$19Royalty or LicenseCash or cash equivalentDORNHOFFER INTERPOSITIONALPORP W TITANIUM CRADLE3 MM OVERALL LENGTH 2 MM FUNCT Device, Ear, Nose, Throat2022
2022-11-14Bausch & Lomb Americas Inc.$239,796Royalty or LicenseCash or cash equivalentVISUDYNE Drug, Ophthalmology2022
2022-11-04Inspire Medical Systems, Inc.$3,275Research paymentCash or cash equivalentInspire Upper Airway Stimulation System Device, NeurologyPREDICTOR STUDY2022
2022-11-01Oyster Point Pharma, Inc.$8,500Research paymentCash or cash equivalentA PHASE 2, MULTICENTER, RANDOMIZED, CONTROLLED, DOUBLE-MASKED CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF OC-02022
2022-11-01Genentech, Inc.$2,812Research paymentCash or cash equivalent DrugPHASE 2 OF RO7171009 IN GA2022
2022-10-28ABBVIE INC.$5,000GrantCash or cash equivalentCOMBIGAN Drug, OPHTHALMOLOGY2022
2022-10-25Grace Medical, Inc.$135Royalty or License (4 payments)Cash or cash equivalentOTOSHIELD PROTECTIVE BARRIER DRAPE Medical Supply, OTOLOGY2022
2022-10-13Biogen, Inc.$16,055Research paymentCash or cash equivalentA Long-term Follow-up Study to Evaluate the Safety and Efficacy of Retinal Gene Therapy in Subjects with Choroideremia P2022
2022-10-06Alcon Research LLC$96,000Research paymentCash or cash equivalentA Phase 3 Study Evaluating the Safety and Efficacy of AR-15512, a Cold Thermoreceptor Modulator, for the Treatment of Dr2022
2022-10-04Genentech, Inc.$3,000Research paymentCash or cash equivalent DrugPHASE 2 OF RO7171009 IN GA2022
2022-10-04Genentech, Inc.$3,000Research paymentCash or cash equivalent DrugPHASE 2 OF RO7171009 IN GA2022
2022-09-15Genentech, Inc.$249,688Research paymentCash or cash equivalent DrugPRE-CLINICAL091520222022
2022-08-23Biogen, Inc.$50,000Royalty or LicenseCash or cash equivalent2022
2022-08-14Bausch & Lomb Americas Inc.$128,669Royalty or LicenseCash or cash equivalentVISUDYNE Drug, Ophthalmology2022
2022-08-11Optinose US, Inc.$795Research paymentCash or cash equivalentA 24-Week Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating the Efficacy and Sa2022
2022-08-03Bausch & Lomb Americas Inc.$10,000GrantCash or cash equivalent2022
2022-08-01Gyrus ACMI, Inc.$13Royalty or LicenseCash or cash equivalentDORNHOFFER INTERPOSITIONALPORP W TITANIUM CRADLE3 MM OVERALL LENGTH 2 MM FUNCT Device, Ear, Nose, Throat2022
2022-07-21Genentech, Inc.$14,344Research paymentCash or cash equivalent DrugPHASE 2 OF RO7171009 IN GA2022
2022-07-13Medtronic, Inc.$8,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentMIDAS REX Device, High Speed Surgical Drills and Tools2022
2022-07-06Oyster Point Pharma, Inc.$715Research paymentCash or cash equivalentA PHASE 2, MULTICENTER, RANDOMIZED, CONTROLLED, DOUBLE-MASKED CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF OC-02022
2022-07-05Alcon Research LLC$96,000Research paymentCash or cash equivalentA Phase 3 Study Evaluating the Safety and Efficacy of AR-15512, a Cold Thermoreceptor Modulator, for the Treatment of Dr2022
2022-05-15Bausch & Lomb Americas Inc.$177,813Royalty or LicenseCash or cash equivalentVISUDYNE Drug, Ophthalmology2022
2022-05-13Inspire Medical Systems, Inc.$150Research paymentCash or cash equivalentInspire Upper Airway Stimulation System Device, NeurologyHOME STUDY2022
2022-04-20Advanced Bionics, LLC$102Research paymentIn-kind items and servicesHIRES ULTRA CI HIFOCUS MS ELECTRODE Device, OTOLARYNGOLOGYDevelopment and assessment of listener-tailored CI programming2022
2022-04-13Spark Therapeutics, Inc.$1,837Research paymentCash or cash equivalentLUXTURNA Biological, OCULARA POST-AUTHORIZATION, MULTICENTER, LONGITUDINAL, OBSERVATIONAL SAFETY REGISTRY STUDY FOR PATIENTS TREATED WITH VORETIGEN2022
2022-03-23Advanced Bionics, LLC$2,078Research paymentIn-kind items and servicesHIRES ULTRA CI HIFOCUS MS ELECTRODE Device, OTOLARYNGOLOGYDevelopment and assessment of listener-tailored CI programming2022
2022-02-18EMD Millipore Corporation$185Royalty or LicenseCash or cash equivalent Device, DIAGNOSTIC TESTING2022
2022-02-14Bausch & Lomb Americas Inc.$148,170Royalty or LicenseCash or cash equivalentVISUDYNE Drug, Ophthalmology2022
2022-02-11Stryker Corporation$3,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentCAPRI CORPECTOMY CAGE SYSTEM Device, SPINE2022
2022-02-07Biogen, Inc.$26,848Research paymentCash or cash equivalentAn Open-Label Safety Study of Retinal Gene Therapy for Choroideremia with Bilateral, Sequential Administration of Adeno-2022
2022-02-04Inspire Medical Systems, Inc.$3,790Research paymentCash or cash equivalentInspire Upper Airway Stimulation System Device, NeurologyHOME STUDY2022
2022-02-04Inspire Medical Systems, Inc.$100Research paymentIn-kind items and servicesInspire Upper Airway Stimulation System Device, NeurologyPEDIATRIC PAS STUDY2022
2022-01-31Oyster Point Pharma, Inc.$10,000Research paymentCash or cash equivalentA PHASE 2, MULTICENTER, RANDOMIZED, CONTROLLED, DOUBLE-MASKED CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF OC-02022
2022-01-31Oyster Point Pharma, Inc.$36Research paymentCash or cash equivalentA PHASE 2, MULTICENTER, RANDOMIZED, CONTROLLED, DOUBLE-MASKED CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF OC-02022
2022-01-28Celgene Corporation$100,000Research paymentCash or cash equivalentPhase Ib Motolimod Pre Surgerical Biomarker SCCHN (VTX-2337-HN-001) (BMS Study Number: CA075-P01)2022
2022-01-25Oyster Point Pharma, Inc.$125Research paymentCash or cash equivalentA PHASE 2, MULTICENTER, RANDOMIZED, CONTROLLED, DOUBLE-MASKED CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF OC-02022
2022-01-20MED-EL Corporation$6,530Research paymentIn-kind items and servicesADHEAR Professional Kit Device, Bone Conduction SystemADHEAR in infants with Down Syndrome and minimal hearing loss2022
2022-01-14Biogen, Inc.$11,648Royalty or LicenseCash or cash equivalent2022
2022-01-14Biogen, Inc.$9,975Royalty or LicenseCash or cash equivalent2022
2022-01-14Biogen, Inc.$1,875Royalty or LicenseCash or cash equivalent2022
2022-01-12Optinose US, Inc.$4,906Research paymentCash or cash equivalentA 24-Week Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating the Efficacy and Sa2022

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Suffolk CountyBoston city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Boston, MA, county Suffolk County, MA, state Massachusetts; placed by its city name.

MeasurePlace (city or town)
Boston, MA
County
Suffolk County, MA
State
Massachusetts
Population B01003666,442785,1217,044,056
Population, 2020 census P1675,647797,9367,029,917
Median age B0100233.333.940.0
Under 18 B0100115.1%16.0%19.4%
65 and over B0100113.0%13.3%17.9%
Households B11001283,374327,1672,785,042
Foreign born B0500227.8%29.8%18.0%
Median household income B19013$97,344$95,631$103,960
Median family income B19113$116,436$112,072$131,675
Per capita income B19301$61,698$58,636$57,897
Poverty rate B1700116.6%16.2%10.0%
Unemployment rate B230256.1%6.3%5.2%
Civilian labor force B23025402,354468,6363,911,446
Mean commute (minutes) B0801330.330.929.1
Bachelor's degree or higher B1500354.9%50.6%47.3%
Housing units B25001310,625357,2903,030,406
Owner-occupied B2500335.7%36.5%62.5%
Renters B2500364.3%63.5%37.5%
Median home value B25077$731,700$705,800$562,100
Median gross rent B25064$2,147$2,129$1,762
White, not Hispanic B0300244.1%43.6%66.6%
Black B0300219.3%17.1%6.4%
Hispanic or Latino B0300219.3%23.2%13.3%
Asian B0300210.3%9.2%7.3%
American Indian and Alaska Native B030020.1%0.1%0.1%

Economy now FRED unemployment 4.3% in Sep 2026 (4.6% a year earlier); per capita personal income $98,700 in 2025, up 27% in five years (+2.3% after inflation); Unemployment rate: 3.8% in Sep 2016 to 4.3% in Sep 2026; low 3.0%, high 17.8% the state; Source: FRED, Federal Reserve Bank of St. Louis.

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Boston, MA.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.